3 news items
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
OCUP
VTRS
10 May 24
and uncertainties posed by many factors and events that could cause our actual business, prospects and results of operations to differ materially from
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
VTRS
27 Mar 24
results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute
Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris
VTRS
11 Mar 24
in the stock-for-stock exchange conducted pursuant to the offering materials issued in connection
- Prev
- 1
- Next